Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors.

Autor: Khazamipour N; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Oo HZ; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada.; Molecular Pathology & Cell Imaging Laboratory, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Al-Nakouzi N; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Marzban M; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Khazamipour N; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Roberts ME; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Farivar N; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Moskalev I; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Lo J; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Ghaidi F; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Nelepcu I; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Moeen A; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Truong S; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Dagil R; Centre for Translational Medicine and Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Choudhary S; Centre for Translational Medicine and Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Gustavsson T; Centre for Translational Medicine and Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Zhai B; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Heitzender S; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Salanti A; Centre for Translational Medicine and Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Sorensen PH; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark.; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Daugaard M; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. mads.daugaard@ubc.ca.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada. mads.daugaard@ubc.ca.; Molecular Pathology & Cell Imaging Laboratory, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada. mads.daugaard@ubc.ca.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark. mads.daugaard@ubc.ca.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2024 Nov; Vol. 16 (11), pp. 2775-2794. Date of Electronic Publication: 2024 Oct 15.

Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.

Autor: Vidal-Calvo EE; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark. elena@sund.ku.dk.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark. elena@sund.ku.dk., Martin-Salazar A; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Choudhary S; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Dagil R; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Raghavan SSR; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Duvnjak L; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Nordmaj MA; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Clausen TM; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Skafte A; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Oberkofler J; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Wang K; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Agerbæk MØ; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VARCT Diagnostics, Copenhagen, Denmark., Løppke C; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Jørgensen AM; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VARCT Diagnostics, Copenhagen, Denmark., Ropac D; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Mujollari J; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Willis S; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Garcias López A; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Miller RL; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Karlsson RTG; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Goerdeler F; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Chen YH; GlycoDisplay ApS, Copenhagen, Denmark., Colaço AR; Proteomics Research Infrastructure, University of Copenhagen, Copenhagen, Denmark., Wang Y; College of Life Sciences, Zhejiang University, Hangzhou, China., Lavstsen T; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark., Martowicz A; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Nelepcu I; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Marzban M; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Oo HZ; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Ørum-Madsen MS; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Wang Y; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada., Nielsen MA; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Clausen H; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Wierer M; Proteomics Research Infrastructure, University of Copenhagen, Copenhagen, Denmark., Wolf D; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Gögenur I; Center for Surgical Science, Department of Surgery, Zealand University Hospital Køge, Køge, Denmark., Theander TG; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Al-Nakouzi N; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Gustavsson T; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark., Daugaard M; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark. mads.daugaard@ubc.ca.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institutes, Vancouver, BC, Canada. mads.daugaard@ubc.ca.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. mads.daugaard@ubc.ca., Salanti A; Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark. salanti@sund.ku.dk.; VAR2 Pharmaceuticals ApS, Copenhagen, Denmark. salanti@sund.ku.dk.

Publikováno v: Nature communications [Nat Commun] 2024 Aug 30; Vol. 15 (1), pp. 7553. Date of Electronic Publication: 2024 Aug 30.

Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer.

Autor: Al-Nakouzi N; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada. nalnakouzi@prostatecentre.com.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada. nalnakouzi@prostatecentre.com., Wang CK; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Oo HZ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Nelepcu I; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Lallous N; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Spliid CB; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and Department of Infectious Disease, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA., Khazamipour N; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Lo J; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Truong S; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Collins C; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Hui D; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Esfandnia S; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Adomat H; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Clausen TM; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and Department of Infectious Disease, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA., Gustavsson T; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and Department of Infectious Disease, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2pharmaceuticals Ole Maaløes Vej 3, 2200, København, Denmark., Choudhary S; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and Department of Infectious Disease, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2pharmaceuticals Ole Maaløes Vej 3, 2200, København, Denmark., Dagil R; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and Department of Infectious Disease, Copenhagen University Hospital, Copenhagen, Denmark.; VAR2pharmaceuticals Ole Maaløes Vej 3, 2200, København, Denmark., Corey E; Department of Urology, University of Washington, Seattle, WA, 98195, USA., Wang Y; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Chauchereau A; Prostate Cancer Group, INSERM UMR981, Gustave Roussy, University of Paris-Saclay, F-94805, Villejuif, France., Fazli L; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Esko JD; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA., Salanti A; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and Department of Infectious Disease, Copenhagen University Hospital, Copenhagen, Denmark., Nelson PS; Department of Urology, University of Washington, Seattle, WA, 98195, USA.; Fred Hutchinson Cancer Centre, Seattle, WA, 98109-1024, USA., Gleave ME; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada. mads.daugaard@ubc.ca.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada. mads.daugaard@ubc.ca.

Publikováno v: Nature communications [Nat Commun] 2022 Aug 13; Vol. 13 (1), pp. 4760. Date of Electronic Publication: 2022 Aug 13.

Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer.

Autor: Oo HZ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada., Lohinai Z; Department of Tumor Biology, National Koranyi Institute of Pulmonology, 1122 Budapest, Hungary., Khazamipour N; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada., Lo J; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada., Kumar G; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada., Pihl J; Department of Cellular and Molecular Medicine, University of California, La Jolla, San Diego, CA 92093, USA., Adomat H; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada., Nabavi N; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada., Behmanesh H; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada., Zhai B; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada., Dagil R; Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Choudhary S; Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Gustavsson T; Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Clausen TM; Department of Cellular and Molecular Medicine, University of California, La Jolla, San Diego, CA 92093, USA., Esko JD; Department of Cellular and Molecular Medicine, University of California, La Jolla, San Diego, CA 92093, USA., Allen JW; Kootenai Health, Post Falls, ID 83854, USA., Thompson MA; Aurora Cancer Care, Advocate Aurora Health, Milwaukee, WI 53215, USA., Tran NL; Department of Cancer Biology, Mayo Clinic, Scottsdale, AZ 85259, USA., Moldvay J; Department of Tumor Biology, National Koranyi Institute of Pulmonology, 1122 Budapest, Hungary.; MTA-SE NAP, Brain Metastasis Research Group, Department of Pathology, Hungarian Academy of Sciences, 1085 Budapest, Hungary., Dome B; Department of Tumor Biology, National Koranyi Institute of Pulmonology, 1122 Budapest, Hungary.; Department of Thoracic Surgery, National Institute of Oncology, Semmelweis University, 1122 Budapest, Hungary.; Department of Thoracic Surgery, Medical University of Vienna, 1090 Vienna, Austria., Salanti A; Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Al-Nakouzi N; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada., Weiss GJ; MiRanostics Consulting, Oro Valley, AZ 85755, USA., Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC V6H 3Z6, Canada.

Publikováno v: Cancers [Cancers (Basel)] 2021 Sep 06; Vol. 13 (17). Date of Electronic Publication: 2021 Sep 06.

Discriminating Benign from Malignant Lung Diseases Using Plasma Glycosaminoglycans and Cell-Free DNA.

Autor: Qvick, Alvida¹ (AUTHOR) alvida.qvick@regionorebrolan.se, Bratulic, Sinisa² (AUTHOR), Carlsson, Jessica³ (AUTHOR), Stenmark, Bianca¹ (AUTHOR), Karlsson, Christina⁴ (AUTHOR) christina.karlsson@oru.se, Nielsen, Jens^2,5 (AUTHOR), Gatto, Francesco^2,6 (AUTHOR), Helenius, Gisela¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p9777. 11p.